Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 23, 2026 5.602B
October 22, 2026 5.993B
October 21, 2026 6.400B
October 20, 2026 6.370B
October 19, 2026 5.877B
October 16, 2026 5.500B
October 15, 2026 6.126B
October 14, 2026 5.739B
October 13, 2026 5.827B
October 12, 2026 7.543B
October 09, 2026 7.824B
October 08, 2026 6.593B
October 07, 2026 7.394B
October 06, 2026 7.515B
October 05, 2026 7.995B
October 02, 2026 7.809B
October 01, 2026 7.796B
September 30, 2026 8.161B
September 29, 2026 8.228B
September 28, 2026 8.357B
September 25, 2026 8.216B
September 24, 2026 8.402B
September 23, 2026 8.201B
September 22, 2026 8.806B
September 21, 2026 8.085B
Date Value
September 18, 2026 7.598B
September 17, 2026 8.251B
September 16, 2026 7.540B
September 15, 2026 7.756B
September 14, 2026 8.301B
September 11, 2026 7.766B
September 10, 2026 7.683B
September 09, 2026 8.118B
September 08, 2026 8.251B
September 04, 2026 9.532B
September 03, 2026 9.311B
September 02, 2026 9.545B
September 01, 2026 9.076B
August 31, 2026 8.992B
August 28, 2026 9.109B
August 27, 2026 11.45B
August 26, 2026 11.74B
August 25, 2026 12.12B
August 24, 2026 11.81B
August 21, 2026 12.75B
August 20, 2026 11.32B
August 19, 2026 11.88B
August 18, 2026 6.766B
August 17, 2026 6.478B
August 14, 2026 6.852B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Moderna, Inc. 75.99B
Mereo BioPharma Group Plc 15.88M
NuCana Plc -20.75M
Immatics NV 566.19M